Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Conjoint analysis versus rating and ranking for values elicitation and clarification in colorectal cancer screening.

Pignone MP, Brenner AT, Hawley S, Sheridan SL, Lewis CL, Jonas DE, Howard K.

J Gen Intern Med. 2012 Jan;27(1):45-50. doi: 10.1007/s11606-011-1837-z. Epub 2011 Aug 26.

2.

Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia.

Brenner A, Howard K, Lewis C, Sheridan S, Crutchfield T, Hawley S, Reuland D, Kistler C, Pignone M.

J Gen Intern Med. 2014 Mar;29(3):507-13. doi: 10.1007/s11606-013-2701-0. Epub 2013 Nov 23.

3.

Comparing 3 techniques for eliciting patient values for decision making about prostate-specific antigen screening: a randomized controlled trial.

Pignone MP, Howard K, Brenner AT, Crutchfield TM, Hawley ST, Lewis CL, Sheridan SL.

JAMA Intern Med. 2013 Mar 11;173(5):362-8. doi: 10.1001/jamainternmed.2013.2651.

4.

Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina.

Pignone MP, Crutchfield TM, Brown PM, Hawley ST, Laping JL, Lewis CL, Lich KH, Richardson LC, Tangka FK, Wheeler SB.

BMC Health Serv Res. 2014 Nov 30;14:611. doi: 10.1186/s12913-014-0611-4.

5.

Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?

Veldwijk J, Essers BA, Lambooij MS, Dirksen CD, Smit HA, de Wit GA.

Value Health. 2016 Mar-Apr;19(2):202-9. doi: 10.1016/j.jval.2015.11.004. Epub 2016 Jan 7.

6.

Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.

Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S.

Med Care. 2008 Sep;46(9 Suppl 1):S10-6. doi: 10.1097/MLR.0b013e31817d932e.

PMID:
18725820
7.

Older adults' preferences for colorectal cancer-screening test attributes and test choice.

Kistler CE, Hess TM, Howard K, Pignone MP, Crutchfield TM, Hawley ST, Brenner AT, Ward KT, Lewis CL.

Patient Prefer Adherence. 2015 Jul 15;9:1005-16. doi: 10.2147/PPA.S82203. eCollection 2015.

8.

Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.

Wong MC, John GK, Hirai HW, Lam TY, Luk AK, Ching JY, Ng SS, Chan FK, Griffiths SM, Sung JJ.

Cancer Causes Control. 2012 Sep;23(9):1541-8. doi: 10.1007/s10552-012-0031-x. Epub 2012 Jul 27.

PMID:
22836914
9.

Eliciting public preferences for healthcare: a systematic review of techniques.

Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, Napper M, Robb CM.

Health Technol Assess. 2001;5(5):1-186.

10.

Eliciting population preferences for mass colorectal cancer screening organization.

Nayaradou M, Berchi C, Dejardin O, Launoy G.

Med Decis Making. 2010 Mar-Apr;30(2):224-33. doi: 10.1177/0272989X09342747. Epub 2009 Aug 19.

PMID:
19692710
11.

Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).

Denters MJ, Deutekom M, Essink-Bot ML, Bossuyt PM, Fockens P, Dekker E.

Health Expect. 2015 Oct;18(5):839-49. doi: 10.1111/hex.12056. Epub 2013 Feb 25.

12.

Preferences for colorectal cancer screening strategies: a discrete choice experiment.

Hol L, de Bekker-Grob EW, van Dam L, Donkers B, Kuipers EJ, Habbema JD, Steyerberg EW, van Leerdam ME, Essink-Bot ML.

Br J Cancer. 2010 Mar 16;102(6):972-80. doi: 10.1038/sj.bjc.6605566. Epub 2010 Mar 2.

13.

An empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening.

Cheng J, Pullenayegum E, Marshall DA, Marshall JK, Thabane L.

BMC Med Res Methodol. 2012 Feb 20;12:15. doi: 10.1186/1471-2288-12-15.

14.

Randomized trial of presenting absolute v. relative risk reduction in the elicitation of patient values for heart disease prevention with conjoint analysis.

Griffith JM, Lewis CL, Hawley S, Sheridan SL, Pignone MP.

Med Decis Making. 2009 Mar-Apr;29(2):167-74. doi: 10.1177/0272989X08327492. Epub 2009 Mar 11.

PMID:
19279298
15.

Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.

Wortley S, Wong G, Kieu A, Howard K.

Patient. 2014;7(3):271-82. doi: 10.1007/s40271-014-0054-3. Review.

PMID:
24652475
16.

The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.

Benning TM, Dellaert BG, Severens JL, Dirksen CD.

Value Health. 2014 Jul;17(5):578-87. doi: 10.1016/j.jval.2014.04.007. Epub 2014 Jun 30.

17.

Colorectal cancer risk information presented by a nonphysician assistant does not increase screening rates.

Wilkins T, Gillies RA, Panchal P, Patel M, Warren P, Schade RR.

Can Fam Physician. 2014 Aug;60(8):731-8.

18.

Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Winship I, Giles GG, Hopper JL, Jenkins MA.

Cancer Causes Control. 2012 Nov;23(11):1853-64. doi: 10.1007/s10552-012-0067-y. Epub 2012 Sep 26.

19.

Willingness to take a screening test for colorectal cancer: a community-based survey in Malaysia.

Naing C, Jun YK, Yee WM, Waqiyuddin SJ, Lui LC, Shaung OY, Haw FJ.

Eur J Cancer Prev. 2014 Mar;23(2):71-5. doi: 10.1097/CEJ.0b013e328362e9b4.

PMID:
23722440
20.

A comparison of US and Australian men's values and preferences for PSA screening.

Howard K, Brenner AT, Lewis C, Sheridan S, Crutchfield T, Hawley S, Nielsen ME, Pignone MP.

BMC Health Serv Res. 2013 Oct 5;13:388. doi: 10.1186/1472-6963-13-388.

Supplemental Content

Support Center